Trademark applications and grants for Eisai Co L T D. Eisai Co L T D has 42 trademark applications. The latest application filed is for "AMPARESTA"
Patent Application | Date |
---|---|
ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE 20170252458 - 15/448497 Albone; Earl F ;   et al. | 2017-09-07 |
HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER 20140309174 - 14/077660 Kowalczyk; James J. ;   et al. | 2014-10-16 |
MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS 20130196987 - 13/663857 Boivin; Roch ;   et al. | 2013-08-01 |
HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER 20120309938 - 13/365728 KOWALCZYK; James J. ;   et al. | 2012-12-06 |
3,5-DISUBSTUTUTED 1H-PYRROLO [2,3-B] PYRIDINES AS JNK INHIBITORS 20110166173 - 10/591551 Medland; Darren Peter ;   et al. | 2011-07-07 |
NCAGE Code | SYC66 | EISAI CO., LTD. |
CAGE Code | SYC66 | EISAI CO., LTD. |
SEC | 0000031898 | EISAI CO LTD/ADR |
SEC | 0000948406 | EISAI CO LTD /FI |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.